Sage Still Sees Approval Path After Depression Drug Fails In Phase III Trial

 
• By Leah Samuel
  
Sunrise in Snowy Mountains
The Phase III MOUNTAIN trial missed the primary endpoint
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D